US FDA to convene expert panel to review wider access to some peptides Reuters Hims & Hers stock rises 14% as FDA schedules peptide compounding review The FDA just put peptides like BPC 157, TB 500, and KPV on the clock. , As a compounding pharmacist, this is literally my world and most people dont understand the regulatory nuance behind what BPC 157 Benefits: Heal & Thrive in 2025 FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA Sends Warning Letters to More Than 50 GLP 1 Compounders and Manufacturers Wilson Sonsini